Studying surgery types for early-stage ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had early-stage epithelial ovarian cancer before surgery
- Your surgery was between January 2014 and December 2023
- You had either open or minimally invasive surgery (laparoscopic or robotic) to stage or restage the cancer
- Your final lab results confirmed epithelial ovarian cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
This trial tests whether using a small-scope (minimally invasive) surgery instead of a large incision can safely remove remaining ovarian cancer after chemotherapy. It may mean a faster recovery and fewer complications.
This trial studies removing the pelvic lining (peritoneum) during surgery for early-stage ovarian or fallopian tube tumors. It aims to see if this extra step improves outcomes.
This trial studies whether an additional treatment after surgery can help people with early-stage epithelial ovarian cancer live longer and stay well for more time. It is meant for patients who had a detailed staging operation and are able to start treatment within 8 weeks.
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
This study looks at women with advanced ovarian cancer to see if certain factors can predict the type of cancer and how well surgery will work. It may help doctors plan the best treatment for you.
Hear when a new Early-stage Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.